Page 2 of Hepatitis B

BMS, Cipla may settle patent row amicably

Bristol-Myers Squibb and Cipla are heading towards an amicable settlement on a long-stretched patent row over Entecavir, a pharmaceutical combination…

April 29, 2015 02:35 IST

« Prev

Related News

Kolhapur girl who worked on factory floors now leads a $19 billion global luxury brand

Indian Railways, Railway, Special Train, Maharashtra, Gujarat, Western Railway

Western Railway cancels 5 trains on Maharashtra, Gujarat routes; Check Full List and affected stations

Jefferies stock picks, Jefferies Buy rating, Jefferies target price, ONGC share price target

3 ‘Buy’ recommendations by Jefferies with 20% to 30% upside potential

Share market, Nifty, Sensex today, July 14

Stocks making the biggest moves midday: Britannia, Trent, Siemens Energy, Waaree and more

Ambala, Chandigarh highway, Zirakpur bypass, Roadways, Highways, Expressway, Dera Bassi

New six-lane link from Ambala-Chandigarh highway to Zirakpur bypass coming up in Dec — Dera Bassi traffic set for relief

UPI MDR Row: Is the US trade factor behind India’s digital payments debate? | Explained

India News1 hr ago

The Finance Ministry’s proposal to impose fees on UPI and RuPay debit card payments has sparked concerns over the influence of the “Trump factor” on India’s digital payments policy. While the government justifies it as necessary for the UPI ecosystem’s financial sustainability, experts fear it may be a response to US pressure.

View all shorts

Market Pulse

Page 2 of Hepatitis B

Related News

Trending Topics